501 related articles for article (PubMed ID: 10966544)
1. Pilsicainide for conversion and maintenance of sinus rhythm in chronic atrial fibrillation: a placebo-controlled, multicenter study.
Okishige K; Nishizaki M; Azegami K; Igawa M; Yamawaki N; Aonuma K;
Am Heart J; 2000 Sep; 140(3):e13. PubMed ID: 10966544
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological conversion of persistent atrial fibrillation into sinus rhythm with oral pilsicainide: pilsicainide suppression trial for persistent atrial fibrillation II.
Okishige K; Fukunami M; Kumagai K; Atarashi H; Inoue H;
Circ J; 2006 Jun; 70(6):657-61. PubMed ID: 16723783
[TBL] [Abstract][Full Text] [Related]
3. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study.
Bianconi L; Mennuni M; Lukic V; Castro A; Chieffi M; Santini M
J Am Coll Cardiol; 1996 Sep; 28(3):700-6. PubMed ID: 8772759
[TBL] [Abstract][Full Text] [Related]
4. External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis.
Kukendrarajah K; Ahmad M; Carrington M; Ioannou A; Taylor J; Razvi Y; Papageorgiou N; Mead GE; Nevis IF; D'Ascenzo F; Wilton SB; Lambiase PD; Morillo CA; Kwong JS; Providencia R
Cochrane Database Syst Rev; 2024 Jun; 6(6):CD013255. PubMed ID: 38828867
[TBL] [Abstract][Full Text] [Related]
5. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
Frick M; Darpö B; Ostergren J; Rosenqvist M
Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301
[TBL] [Abstract][Full Text] [Related]
6. Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct-current cardioversion.
Opolski G; Stanisławska J; Górecki A; Swiecicka G; Torbicki A; Kraska T
Clin Cardiol; 1997 Apr; 20(4):337-40. PubMed ID: 9098591
[TBL] [Abstract][Full Text] [Related]
7. A randomized study on the efficacy of intravenous cibenzoline and pilsicainide administered prior to electrical cardioversion in patients with lone paroxysmal and persistent atrial fibrillation.
Komatsu T; Tachibana H; Sato Y; Ozawa M; Ohshima K; Orii M; Kunigida F; Nakamura M
J Cardiol; 2009 Feb; 53(1):35-42. PubMed ID: 19167636
[TBL] [Abstract][Full Text] [Related]
8. Conversion of recent-onset Atrial Fibrillation by a single oral dose of Pilsicainide (Pilsicainide Suppression Trial on atrial fibrillation). The PSTAF Investigators.
Atarashi H; Inoue H; Hiejima K; Hayakawa H
Am J Cardiol; 1996 Sep; 78(6):694-7. PubMed ID: 8831412
[TBL] [Abstract][Full Text] [Related]
9. Rate of conversion and recurrence after sotalol treatment in patients with direct current-refractory atrial fibrillation.
Nergärdh A; Nordlander R; Frick M
Clin Cardiol; 2006 Feb; 29(2):56-60. PubMed ID: 16506639
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy of hybrid pharmacologic and ablation therapy in patients with pilsicainide-induced atrial flutter.
Hirao K; Okishige K; Yamamoto N; Otomo K; Azegami K; Isobe M
Clin Cardiol; 2005 Jul; 28(7):338-42. PubMed ID: 16075827
[TBL] [Abstract][Full Text] [Related]
11. Maintenance of sinus rhythm and recovery of atrial mechanical function after cardioversion with bepridil or in combination with aprindine in long-lasting persistent atrial fibrillation.
Fujiki A; Tsuneda T; Sakabe M; Nakagawa K; Mizumaki K; Hirai T; Inoue H
Circ J; 2004 Sep; 68(9):834-9. PubMed ID: 15329504
[TBL] [Abstract][Full Text] [Related]
12. Pilsicainide.
Plosker GL
Drugs; 2010 Mar; 70(4):455-67. PubMed ID: 20205487
[TBL] [Abstract][Full Text] [Related]
13. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation.
Capucci A; Villani GQ; Aschieri D; Rosi A; Piepoli MF
Eur Heart J; 2000 Jan; 21(1):66-73. PubMed ID: 10610746
[TBL] [Abstract][Full Text] [Related]
14. Correlation between inflammation state and successful medical cardioversion using bepridil for refractory atrial fibrillation.
Nishino M; Mori N; Nakamura D; Lee Y; Yoshimura T; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
J Cardiol; 2013 Aug; 62(2):117-20. PubMed ID: 23623817
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of vernakalant for the conversion of atrial fibrillation to sinus rhythm; a phase 3b randomized controlled trial.
Beatch GN; Mangal B
BMC Cardiovasc Disord; 2016 May; 16():113. PubMed ID: 27233239
[TBL] [Abstract][Full Text] [Related]
16. Enhancing electrical cardioversion and preventing immediate reinitiation of hemodynamically deleterious atrial fibrillation with class III drug pretreatment.
Hayashi M; Tanaka K; Kato T; Morita N; Sato N; Yasutake M; Kobayashi Y; Takano T
J Cardiovasc Electrophysiol; 2005 Jul; 16(7):740-7. PubMed ID: 16050832
[TBL] [Abstract][Full Text] [Related]
17. Sinus rhythm maintenance following DC cardioversion of atrial fibrillation is not improved by temporary precardioversion treatment with oral verapamil.
Lindholm CJ; Fredholm O; Möller SJ; Edvardsson N; Kronvall T; Pettersson T; Firsovaite V; Roijer A; Meurling CJ; Platonov PG; Olsson SB
Heart; 2004 May; 90(5):534-8. PubMed ID: 15084552
[TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic efficacy of azimilide in patients with atrial fibrillation. Maintenance of sinus rhythm after conversion to sinus rhythm.
Pritchett EL; Kowey P; Connolly S; Page RL; Kerr C; Wilkinson WE;
Am Heart J; 2006 May; 151(5):1043-9. PubMed ID: 16644334
[TBL] [Abstract][Full Text] [Related]
19. Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study.
Crijns HJ; Weijs B; Fairley AM; Lewalter T; Maggioni AP; Martín A; Ponikowski P; Rosenqvist M; Sanders P; Scanavacca M; Bash LD; Chazelle F; Bernhardt A; Gitt AK; Lip GY; Le Heuzey JY
Int J Cardiol; 2014 Apr; 172(3):588-94. PubMed ID: 24556445
[TBL] [Abstract][Full Text] [Related]
20. Factors predicting maintenance of sinus rhythm after direct current cardioversion of atrial fibrillation and flutter: a reanalysis with recently acquired data.
Arnar DO; Danielsen R
Cardiology; 1996; 87(3):181-8. PubMed ID: 8725311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
